Christopher R. Cabanski

发表

ReQON: a Bioconductor package for recalibrating quality scores from next-generation sequencing data

Joel S. Parker, J. S. Marron, Matthew D. Wilkerson, 2012, BMC Bioinformatics.

Comprehensive genomic characterization of squamous cell lung cancers

Steven J. M. Jones, Joshua M. Stuart, Brian D. O’Connor, 2012, Nature.

Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets.

Christopher R. Cabanski, D. Hayes, M. Wilkerson, 2013, Archives of pathology & laboratory medicine.

Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types

Christopher R. Cabanski, C. Perou, D. Hayes, 2010, Clinical Cancer Research.

Pan-cancer transcriptome analysis reveals long noncoding RNAs with conserved function

Christopher R. Cabanski, Ha X. Dang, C. Maher, 2015, RNA biology.

SigFuge: single gene clustering of RNA-seq reveals differential isoform usage among cancer samples

Christopher R. Cabanski, Patrick K. Kimes, J. Marron, 2014, Nucleic acids research.

Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer

Christopher R. Cabanski, C. Maher, R. Govindan, 2014, Genome Biology.

Integrated RNA and DNA sequencing improves mutation detection in low purity tumors

Christopher R. Cabanski, Lisle E. Mose, C. Perou, 2014, Nucleic acids research.

Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes

Christopher R. Cabanski, A. Olshan, D. Hayes, 2013, PloS one.

A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjects.

Christopher R. Cabanski, Yuan Chen, Jeffrey M Harris, 2021, Pulmonary pharmacology & therapeutics.

Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation

Matthew D. Wilkerson, Charles M. Perou, Vonn Walter, 2012, PloS one.

SWISS MADE: Standardized WithIn Class Sum of Squares to Evaluate Methodologies and Dataset Elements

J. S. Marron, Matthew D. Wilkerson, Charles M. Perou, 2010, PloS one.

The clonal evolution of metastatic colorectal cancer

Christopher A. Miller, Christopher R. Cabanski, R. Wilson, 2020, Science Advances.

BlackOPs: increasing confidence in variant detection through mappability filtering

J. S. Marron, Jinze Liu, Matthew D. Wilkerson, 2013, Nucleic acids research.

Statistical Methods for Analysis of Genetic Data

Christopher R. Cabanski, Christopher R. Cabanski, 2012 .

Erratum: Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes (PLoS ONE (2013) 8:7 DOI:10.1371/annotation/b42f61c5-cb7e-49ca-8cd6-6e1f7903ad08)

Christopher R. Cabanski, A. Olshan, D. Hayes, 2013 .

Lung squamous cell carcinoma mRNA expression subtypes are reproducible , clinically important and correspond to different normal cell types

Christopher R. Cabanski, C. Perou, D. Hayes, 2010 .

Title: Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically-important and correspond to different normal cell types

Christopher R. Cabanski, C. Perou, D. Hayes, 2010 .

A phase I, randomized, observer-blinded, single and multiple ascending-dose study to investigate the safety, pharmacokinetics, and immunogenicity of BITS7201A, a bispecific antibody targeting IL-13 and IL-17, in healthy volunteers

Christopher R. Cabanski, Hubert C. Chen, F. Brunstein, 2019, BMC Pulmonary Medicine.

Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.

Christopher R. Cabanski, Matthew J. Brauer, B. Yaspan, 2018, The Lancet. Respiratory medicine.

Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trials.

Christopher R. Cabanski, H. Collard, P. Wolters, 2018, The Lancet. Respiratory medicine.

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Christopher R. Cabanski, Vanessa M. Hubbard-Lucey, E. Wherry, 2022, Nature Medicine.

CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study.

Christopher R. Cabanski, Lacey J. Kitch, Vanessa M. Hubbard-Lucey, 2021, The Lancet. Oncology.

Abstract CT004: A Phase Ib study of CD40 agonistic monoclonal antibody APX005M together with gemcitabine (Gem) and nab-paclitaxel (NP) with or without nivolumab (Nivo) in untreated metastatic ductal pancreatic adenocarcinoma (PDAC) patients

Christopher R. Cabanski, Lacey J. Kitch, Vanessa M. Hubbard-Lucey, 2019, Clinical Trials.

Comprehensive molecular profiling of lung adenocarcinoma

Steven J. M. Jones, Christopher A. Miller, Joshua M. Stuart, 2014, Nature.

Comprehensive molecular profiling of lung adenocarcinoma

Steven J. M. Jones, Christopher A. Miller, Joshua M. Stuart, 2014, Nature.

cDNA hybrid capture improves transcriptome analysis on low-input and archived samples.

Christopher R. Cabanski, R. Fulton, E. Mardis, 2014, The Journal of molecular diagnostics : JMD.

Long non-coding RNA RAMS11 promotes metastatic colorectal cancer progression

Christopher R. Cabanski, Ha X. Dang, R. Wilson, 2020, Nature Communications.

Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses

Christopher R. Cabanski, Daniel K. Wells, P. Gherardini, 2022, Journal for ImmunoTherapy of Cancer.

A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria.

Christopher R. Cabanski, M. Maurer, P. Staubach, 2016, The Journal of allergy and clinical immunology.

Su1220 Rectal Bleeding Accurately Reflects Level of Mucosal Inflammation in Patients With Ulcerative Colitis

Christopher R. Cabanski, J. Mansfield, P. Rutgeerts, 2015 .

Peripheral blood gene expression predicts clinical benefit from anti-IL-13 in asthma.

Christopher R. Cabanski, R. Maciuca, S. Mosesova, 2016, The Journal of allergy and clinical immunology.

Gemcitabine (Gem) and nab-paclitaxel (NP) ± nivolumab (nivo) ± CD40 agonistic monoclonal antibody APX005M (sotigalimab), in patients (Pts) with untreated metastatic pancreatic adenocarcinoma (mPDAC): Phase (Ph) 2 final results.

Christopher R. Cabanski, Lacey J. Kitch, P. Gherardini, 2021 .

A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma

Christopher R. Cabanski, R. Maciuca, I. Agache, 2016, Respiratory Research.

Comprehensive genomic characterization of squamous cell lung cancers

Joshua M. Stuart, Brian D. O’Connor, Charles J. Vaske, 2012, Nature.

Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types

Christopher R. Cabanski, C. Perou, D. Hayes, 2010, Clinical Cancer Research.

Integrated RNA and DNA sequencing improves mutation detection in low purity tumors

Christopher R. Cabanski, Lisle E. Mose, C. Perou, 2014, Nucleic acids research.

Correction: Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes

Christopher R. Cabanski, A. Olshan, D. Hayes, 2013, PLoS ONE.

SigFuge (Tutorial)

Christopher R. Cabanski, P. Kimes, 2013 .